Switzerland-based Nestle has announced the creation of Nestle Health Science and the Nestle Institute of Health Sciences to pioneer a new industry between food and pharmacy.
These two separate organisations will allow Nestle to develop the innovative area of personalised health science nutrition to prevent and treat health conditions such as diabetes, obesity, cardiovascular disease, and Alzheimer’s disease, which are placing an unsustainable burden on the world’s healthcare systems.
Nestle Health Science, a wholly-owned subsidiary of Nestle, will become operational on January 1, 2011. The new company will be run at arm’s length from Nestle’s main food, beverages and nutrition activities, and incorporate the existing global Nestle HealthCare Nutrition business, which had a turnover of CHF 1.6 billion in 2009.
With Health Science, the company aims to have access to external scientific and technological know-how through innovation network as well as a number of venture capital funds in which the group has interests.
The company has also decided to invest hundreds of millions of Swiss francs over the next decade to build an Institute of Health Sciences, which will conduct research in relevant areas of biomedical science to translate this knowledge into nutritional strategies to improve health and longevity. The Institute will be based in the multi-disciplinary scientific environment of the Swiss Federal Institute of Technology (EPFL) in Lausanne, where Nestle is already involved in two life science initiatives. The Nestle Institute of Health Sciences will be part of Nestle’s global R&D network.
No comments:
Post a Comment